Market revenue in 2023 | USD 9,626.3 million |
Market revenue in 2030 | USD 20,548.1 million |
Growth rate | 11.4% (CAGR from 2023 to 2030) |
Largest segment | Medical |
Fastest growing segment | Medical |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Medical, Non-Medical |
Key market players worldwide | Illumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 84.07% in 2023. Horizon Databook has segmented the Europe microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for the second-largest revenue share in 2021. The country has a high demand for diagnostics with growing funding to encourage academic research. For instance, in March 2020, Eden Tech initiated the IPANEMA project, which was financed by the EU Horizon 2020 research and innovation program. The goal of the project was to incorporate paper-based nucleic acid testing methods into microfluidics devices for enhanced biosensing applications, such as the detection of toxigenic freshwater cyanobacteria agrifood pathogen detection and tissue engineering.
In addition, in 2021, the company launched the RENOIR European project: Muscle-on-a-chip for aging, to study how inflammatory response and other factors can hamper the restoration of damaged muscle tissues, and to build a muscle-on-a-chip platform as a prototype for pharmacological assays. During this research, microfluidic devices would be designed and developed to manage the cellular microenvironment. Taking advantage of EDEN Tech expertise and material technology, the microfluidic device will be created using the most appropriate materials for the targeted features and applications. Several organizations are focusing on encouraging collaborations among local manufacturers as well as between local and international manufacturers operating in the microfluidics industry.
For instance, the Centre for Business Innovation held the 10th microfluidics consortium in September 2019. This consortium collaborated with microfluidics stakeholders from Europe and the U.S. to promote the use of state-of-the-art microfluidics technologies across various applications. In addition, the consortium also focused on acknowledging the microfluidics market dynamics and addressing key challenges constraining scale-up and demand.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe microfluidics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe microfluidics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account